Description

Metabolic Dysfunction-Associated Steatohepatitis (MASH) is a chronic liver condition that can lead to serious complications if left undiagnosed or untreated. Characterized by the accumulation of excess fat in the liver (steatosis), inflammation, and ballooning of liver cells, MASH can progress into more severe stages such as liver fibrosis or cirrhosis.

Why Early Detection Matters

MASH is often called a “silent” disease because it may not produce noticeable symptoms in the early stages. This means many individuals remain undiagnosed, increasing the risk of irreversible liver damage. The condition is linked to metabolic dysfunctions such as:

  • Insulin resistance
  • Obesity
  • Type 2 diabetes

Without timely intervention, MASH can lead to serious liver complications, including fibrosis, cirrhosis, or even liver failure.

Fibrosis-4 (FIB-4) Score: A Key Biomarker

The FIB-4 score is a non-invasive blood test used to estimate liver fibrosis. It helps healthcare providers determine whether additional testing is necessary. The score is calculated using:

  • Age
  • AST (Aspartate Aminotransferase)
  • ALT (Alanine Aminotransferase)
  • Platelet count

Interpreting FIB-4 results:

  • Low score: Minimal to no fibrosis; liver likely in early stages or relatively healthy.
  • Moderate to high score: Suggests potential fibrosis or advanced liver damage; additional testing or monitoring may be required.

Fasting is recommended prior to this test to ensure accurate measurement of AST, ALT, and other liver biomarkers, reflecting your body’s baseline metabolic state.

Lipid Panel: Monitoring Metabolic Health

Because MASH is closely associated with metabolic dysfunction, a Lipid Panel is included to evaluate cholesterol and triglyceride levels, helping identify risk factors for cardiovascular disease. Key markers include:

  • Total Cholesterol – Overall level of cholesterol in the blood.
  • LDL (Low-Density Lipoprotein) – “Bad” cholesterol that can contribute to plaque buildup.
  • HDL (High-Density Lipoprotein) – “Good” cholesterol that helps remove excess cholesterol.
  • Triglycerides – Fat molecules in the blood that can indicate metabolic stress.

Monitoring lipid levels alongside liver biomarkers gives a more complete picture of metabolic health and helps guide lifestyle or medical interventions.

Who Should Consider This Panel

  • Individuals with obesity, insulin resistance, or type 2 diabetes
  • Those with a family history of liver disease
  • Individuals experiencing fatigue, unexplained weight gain, or right upper abdominal discomfort (though symptoms may be mild or absent)